[Effect of orally administered lenampicillin and ampicillin on bacterial flora in human adult feces]. 1986

T Motohiro, and A Kawakami, and M Aramaki, and K Tanaka, and T Koga, and Y Shimada, and S Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama

Newly developed lenampicillin (LAPC) which is a prodrug of ampicillin (ABPC), and ampicillin (as the control) were each administered to 6 healthy male volunteers, aged from 21 to 25 years (mean 22.4 years) and weighing 57-78 kg (mean 67.0 kg) to study the effect of LAPC and ABPC on fecal bacterial flora. Each drug was given orally 3 times daily (after meals) with each dose of 250 mg for five days. Changes of the fecal bacterial flora caused by the antibiotic were investigated by determining fecal bacterial counts on the 3rd day before the treatment, 0 (the start of treatment), 3rd and 5th days (the final day of treatment) during treatment, and 3rd, 5th and 10th days after the treatment. Fecal concentrations of LAPC and the metabolites (ABPC, 2-aminobenzyl penicilloic acid (ABPA) and 5S-ABPA) for the LAPC group and ABPC for the ABPC group were assayed. A single dose of 500 mg of LAPC was administered orally after breakfast to additional 6 healthy male volunteers and concentrations of LAPC, metabolites (ABPC, ABPA and 5S-ABPA) in the entire stool were determined daily for 5 successive days after the administration. Clinical adverse reactions and abnormal laboratory-findings caused by either drug were studied in the 18 volunteers. The results obtained are summarized as follows. In the bacterial flora of the 6 volunteers to whom LAPC was administered (the LAPC group), the number of isolated E. coli showed no tend of decrease. Mean bacterial counts obtained 3 days before the treatment and at the day of the treatment were 10(9) and 10(8) cells/g, respectively. These values were compared to the counts obtained on the 3rd and the 5th days during the treatment and were found to be about 10(2)-folds as high as the latter. The decreased counts observed on the 3rd and the 5th days did not last and counts increased again to similar levels observed before the treatment. Klebsiella sp. was isolated from 1 or 2 samples before the treatment. It was isolated from as many as 5-6 cases with mean bacterial counts of 10(7)-10(11) cells/g during and up to 5 days after the treatment. The frequency of isolation then decreased to 4 cases on the 10th day after the treatment.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin

Related Publications

T Motohiro, and A Kawakami, and M Aramaki, and K Tanaka, and T Koga, and Y Shimada, and S Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama
April 1986, The Japanese journal of antibiotics,
T Motohiro, and A Kawakami, and M Aramaki, and K Tanaka, and T Koga, and Y Shimada, and S Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama
January 1986, The Japanese journal of antibiotics,
T Motohiro, and A Kawakami, and M Aramaki, and K Tanaka, and T Koga, and Y Shimada, and S Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama
October 1985, The Japanese journal of antibiotics,
T Motohiro, and A Kawakami, and M Aramaki, and K Tanaka, and T Koga, and Y Shimada, and S Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama
February 1985, The Japanese journal of antibiotics,
T Motohiro, and A Kawakami, and M Aramaki, and K Tanaka, and T Koga, and Y Shimada, and S Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama
September 1949, Journal of bacteriology,
T Motohiro, and A Kawakami, and M Aramaki, and K Tanaka, and T Koga, and Y Shimada, and S Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama
September 1949, Journal of bacteriology,
T Motohiro, and A Kawakami, and M Aramaki, and K Tanaka, and T Koga, and Y Shimada, and S Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama
July 1973, The Journal of pediatrics,
T Motohiro, and A Kawakami, and M Aramaki, and K Tanaka, and T Koga, and Y Shimada, and S Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama
February 1966, Neurologia, neurochirurgia i psychiatria polska,
T Motohiro, and A Kawakami, and M Aramaki, and K Tanaka, and T Koga, and Y Shimada, and S Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama
June 1964, Nihon Shonika Gakkai zasshi. Acta paediatrica Japonica,
T Motohiro, and A Kawakami, and M Aramaki, and K Tanaka, and T Koga, and Y Shimada, and S Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama
January 1953, Voprosy fiziologii,
Copied contents to your clipboard!